Controlling cytokine release involves careful design and engineering of nanomaterials. Surface modifications, such as coating with biocompatible polymers or targeting moieties, can help mitigate unwanted immune responses. Additionally, dosing strategies and delivery mechanisms are optimized to minimize adverse effects.
